Organisation
Internal Medicine Specializations
Department
The department INTG does clinical research concerning pathogenesis, diagnostical and therapeutical interventions in the domain of internal medicine, nephrology, onco-hematology, endocrinology-diabetes, cardiology, geriatry, neurology and pneumology.
Current researchers
1 - 3 of 3 results
- Mandelina Allamani (Member)
- Patrick Haentjens (Member)
- Peter Janssens (Member)
Projects
1 - 8 of 8
- SRP (Groeiers): OPTIMUS – Optimization of stroke careFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
- SRP (Groeiers): Biomarkers for staging diabetes and guiding its prevention and treatmentFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
- Identity and chronic illness: A biopsychosocial analysis of the illness integration continuumFrom1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- IOF-Proof of Concept:PreSSUBFrom1 Nov 2013 → 31 Dec 2015Funding: IOF - Industrial Research Fund
- On the neurophysiology of cognitive deterioration in multiple sclerosisFrom1 Oct 2012 → 30 Sep 2016Funding: FWO fellowships
- IGF-I and mild hypothermia as new therapies for focal cerebral ischemiaFrom1 Jan 2012 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
- Cerebral energy metabolism in multiple sclerosis.From1 Oct 2011 → 30 Sep 2015Funding: FWO fellowships
- BetaCellTherapy : Beta Cell Therapy in Diabetes.From1 Jan 2010 → 30 Jun 2015Funding: Health
Publications
1 - 10 of 876
- EEG in Silent Small Vessel Disease: sLORETA Mapping Reveals Cortical Sources of Vascular Cognitive Impairment No Dementia in the Default Mode Network(2013)
Authors: R. Sheorajpanday, Peter Marien, Arie Weeren, Guy Nagels, Jos Saerens, Michel Van Putten, Peter Paul De Deyn
Pages: 178-187 - Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.(2012)
Authors: Manns M.p., Hendrik Reynaert
Pages: 537-546 - Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study)(2013)
Authors: I Abraham, Karen Macdonald, M. Song, G Ciesielski, C Pacheco, C Lee, M Cholette, K Kinsey, P Speaks, C. Hermans, et al.
Pages: 314-322 - IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?(2011)
Authors: Hendrik Reynaert
Pages: 317-322 - Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort(2012)
Authors: Marc Noppen
Pages: 1334-1342 - Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: A case series with 15-year follow-up(2012)
Authors: Anne Lemy, Karl M Wissing, Sandrine Rorive, Alexandre Zlotta, Thierry Roumeguere, Marie-Carmen Muniz Martinez, Christine Decaestecker, Isabelle Salmon, Daniel Abramowicz, Jean-Louis Vanherweghem, et al.
Pages: 471-477 - Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease(2013)
Authors: Patricia Vanderniepen, D. De Zeeuw
Pages: 2492-2503 - Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors(2012)
Authors: Jan Versijpt
Pages: 141-145 - Genetic forms of nephrotic syndrome: a single-center experience in Brussels(2009)
Authors: Khalid Ismaili, Karl M Wissing, Francoise Janssen, Michelle Hall
Pages: 287-294 - TCF7L2 Polymorphism Associates with New-Onset Diabetes after Transplantation(2009)
Authors: Lidia Ghisdal, Christophe Baron, Yannick Le Meur, Arnaud Lionet, Jean-Michel Halimi, Jean-Philippe Rerolle, Francois Glowacki, Yvon Lebranchu, Mireille Drouet, Christian Noel, et al.
Pages: 2459-2467